ABCP

AMBASE REPORTS RESULTS FOR THE THIRD QUARTER and NINE MONTHS ENDED SEPTEMBER 30, 2023

Retrieved on: 
Thursday, November 9, 2023
Security (finance), Annual report, ABCP, Report, Risk, CORAL, Bank statement, OTC, Cryptocurrency

CORAL SPRINGS, Fla., Nov. 9, 2023 /PRNewswire/ -- AmBase Corporation ("AmBase" or the "Company") (OTC: ABCP) announced today a net loss of $1,399,000 or $0.03 per share for the three months ended September 30, 2023 and a net loss of $3,888,000 or $0.10 per share for the nine months ended September 30, 2023.

Key Points: 
  • CORAL SPRINGS, Fla., Nov. 9, 2023 /PRNewswire/ -- AmBase Corporation ("AmBase" or the "Company") (OTC: ABCP) announced today a net loss of $1,399,000 or $0.03 per share for the three months ended September 30, 2023 and a net loss of $3,888,000 or $0.10 per share for the nine months ended September 30, 2023.
  • For the three months and nine months ended September 30, 2022, the Company recorded a net loss of $717,000 or $0.02 per share and a net loss of $2,757,000 or $0.07 per share, respectiviely.
  • Statements made in this press release may be forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended.
  • Forward-looking statements are inherently subject to risks and uncertainties, many of which cannot be predicted or quantified.

First Immunotherapy Success in TKI-Resistant Lung Cancer Setting Demonstrates Power of AI-driven Immune Phenotyping by Lunit SCOPE IO - newly published in JCO

Retrieved on: 
Tuesday, October 24, 2023
TKI, Bevacizumab, Patient, Pemetrexed, Arm, PC, NSCLC, Carboplatin, CDX, ESMO, Progression-free survival, III, Therapy, Lung cancer, Cisplatin, PFS, European Society for Medical Oncology, Phenotype, Research, TIL, JCO, Journal, Samsung Medical Center, ALK, Journal of Clinical Oncology, Annual general meeting, Immunotherapy, H&E, ORR, Oncology, ABCP, Mutation, EGFR, Pharmaceutical industry, Medical imaging

Against the backdrop of growing interest and need for an AI biomarker in medical practices, this marks the second time a study utilizing Lunit SCOPE IO has been published in the prestigious JCO.

Key Points: 
  • Against the backdrop of growing interest and need for an AI biomarker in medical practices, this marks the second time a study utilizing Lunit SCOPE IO has been published in the prestigious JCO.
  • Lunit SCOPE IO, an AI-powered TIL analyzer for assessing immune phenotype from H&E, played a pivotal role in this research.
  • Immune phenotype as assessed by Lunit SCOPE IO showed predictive power in stratifying patients more likely to respond to ABCP treatment.
  • "We aim for Lunit SCOPE IO to continue to make immune phenotyping a quantitative biomarker readily accessible for research, clinical use, and companion diagnostics (CDx) business."

EQS-News: GRENKE continues to grow in the third quarter of 2023

Retrieved on: 
Tuesday, October 17, 2023
Bicycle industry, DACH, United Kingdom, CM2, EUR, ABCP, LED, Growth, History, Interview, Green economy, SME, Security (finance), Beauty salon, Lithium, Film industry, Renewable energy

In the third quarter of 2023, new leasing business grew for the eighth consecutive quarter, increasing 4.5% to EUR 591.1 million (Q3 2022: EUR 565.5 million).

Key Points: 
  • In the third quarter of 2023, new leasing business grew for the eighth consecutive quarter, increasing 4.5% to EUR 591.1 million (Q3 2022: EUR 565.5 million).
  • Press release on the GRENKE Green Bond from September 22, 2023:
    In the third quarter of 2023, GRENKE again gained new resellers.
  • At EUR 9.6 million, GRENKE Bank's new microcredit business in the third quarter of 2023 was slightly lower year-on-year (Q3 2022: EUR 11.5 million).
  • The factoring business achieved growth of 2.8% in Q3 2023, corresponding to new business volume of EUR 210.7 million (Q3 2022: EUR 205.0 million).

ESMA provides overview of EU securitisation markets

Retrieved on: 
Tuesday, September 26, 2023
Transparency, FR, STS, European Securities and Markets Authority, SECR, EUR, ABS, ABCP, ESMA, SME, Cryptocurrency, EU

ESMA provides overview of EU securitisation markets

Key Points: 
  • ESMA provides overview of EU securitisation markets
    The European Securities and Markets Authority (ESMA), the EU’s financial markets regulator and supervisor, today publishes a study setting out the details of the EU securitisation market.
  • At end-2022, there were 390 individual securitised products outstanding in the EU as reported to the registered securitisation repositories, amounting to EUR 540bn.
  • These securitisations fulfil a various set of predetermined requirements to help investors identify high-quality securitisations and thus foster EU securitisation markets.
  • This article is based on the data ESMA receives under Regulation (EU) 2017/2402 (Securitisation Regulation, or SECR), and on data from the ESMA register of Simple, Transparent and Standardised securitisation (STS) securitisations.

AMBASE REPORTS RESULTS FOR THE SECOND QUARTER and SIX MONTHS ENDED JUNE 30, 2023

Retrieved on: 
Tuesday, August 1, 2023
Risk, Report, ABCP, Annual report, OTC, Security (finance), Bank statement, CORAL, Cryptocurrency

CORAL SPRINGS, Fla., Aug. 1, 2023 /PRNewswire/ -- AmBase Corporation ("AmBase" or the "Company") (OTC: ABCP) announced today a net loss of $1,269,000 or $0.03 per share for the three months ended June 30, 2023 and a net loss of $2,489,000 or $0.06 per share for the six months ended June 30, 2023.

Key Points: 
  • CORAL SPRINGS, Fla., Aug. 1, 2023 /PRNewswire/ -- AmBase Corporation ("AmBase" or the "Company") (OTC: ABCP) announced today a net loss of $1,269,000 or $0.03 per share for the three months ended June 30, 2023 and a net loss of $2,489,000 or $0.06 per share for the six months ended June 30, 2023.
  • For the three months and six months ended June 30, 2022, the Company recorded a net loss of $983,000 or $0.02 per share and a net loss of $2,040,000 or $0.05 per share, respectiviely.
  • Statements made in this press release may be forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended.
  • Forward-looking statements are inherently subject to risks and uncertainties, many of which cannot be predicted or quantified.

AMBASE REPORTS RESULTS FOR THE THREE MONTHS ENDED MARCH 31, 2023

Retrieved on: 
Tuesday, May 2, 2023
Risk, Report, ABCP, Annual report, OTC, Security (finance), Bank statement, CORAL, Cryptocurrency

CORAL SPRINGS, Fla., May 2, 2023 /PRNewswire/ -- AmBase Corporation ("AmBase" or the "Company") (OTC: ABCP) announced today a net loss of $1,220,000 or $0.03 per share for the three months ended March 31, 2023.

Key Points: 
  • CORAL SPRINGS, Fla., May 2, 2023 /PRNewswire/ -- AmBase Corporation ("AmBase" or the "Company") (OTC: ABCP) announced today a net loss of $1,220,000 or $0.03 per share for the three months ended March 31, 2023.
  • For the three months ended March 31, 2022, the Company recorded a net loss of $1,057,000 or $0.03 per share.
  • Statements made in this press release may be forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended.
  • The Company cautions readers that a variety of factors could cause the Company's actual results to differ materially from the anticipated results or other expectations expressed in the Company's forward-looking statements.

EBA consults on the draft Guidelines on the STS criteria for on-balance-sheet securitisations

Retrieved on: 
Friday, April 21, 2023
European Banking Authority, EIOPA, Capital Requirements Regulation 2013, EBA, STS, Ambiguity, CRR, ABCP, European, CEST, Paper, ESMA, Union, Regulation, Guideline, Clothing, Property management, Medical device, EU

21 April 2023

Key Points: 
  • 21 April 2023
    The European Banking Authority (EBA) launched today a public consultation on its draft Guidelines on the criteria related to simplicity, standardisation and transparency and additional specific criteria for on-balance-sheet securitisations (so-called STS criteria).
  • These Guidelines will ensure a harmonised interpretation of these STS criteria, in alignment with the EBA Guidelines for traditional securitisations.
  • With the introduction of STS criteria for on-balance-sheet securitisations in the Securitisation Regulation, on-balance-sheet securitisations are now eligible for preferential risk-weight treatment under the Capital Requirements Regulation (CRR).
  • The draft Guidelines also propose targeted amendments to the Guidelines for non-ABCP securitisation and ABCP securitisation.

AMBASE REPORTS RESULTS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022

Retrieved on: 
Tuesday, March 28, 2023
Risk, Report, ABCP, Annual report, OTC, Hyatt, Security (finance), Bank statement, CORAL, Cryptocurrency

CORAL SPRINGS, Fla., March 28, 2023 /PRNewswire/ -- AmBase Corporation ("AmBase" or the "Company") (OTC: ABCP) announced today a net loss of $3,473,000 or $0.09 per share for the twelve months ended December 31, 2022.

Key Points: 
  • CORAL SPRINGS, Fla., March 28, 2023 /PRNewswire/ -- AmBase Corporation ("AmBase" or the "Company") (OTC: ABCP) announced today a net loss of $3,473,000 or $0.09 per share for the twelve months ended December 31, 2022.
  • For the twelve months ended December 31, 2021, the Company recorded a net loss of $5,208,000 or $0.13 per share.
  • Statements made in this press release may be forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended.
  • A more complete discussion of the Company's annual results and the Company's affairs is included in AmBase Corporation's Annual Report on 10-K for the annual period December 31, 2022, filed with the Securities and Exchange Commission.

EBA publishes final draft technical standards defining the homogeneity of the underlying exposures in STS securitisation

Retrieved on: 
Monday, February 20, 2023
European Banking Authority, RTS, EIOPA, STS, ESMA, Regulation, ABCP, EBA, European, Cryptocurrency, EU

14 February 2023

Key Points: 
  • 14 February 2023
    The European Banking Authority (EBA) published today its final draft Regulatory Technical Standards (RTS) setting out the conditions for the assessment of the homogeneity of the underlying exposures in a pool of a Simple Transparent and Standardised (STS) on-balance-sheet securitisation.
  • Homogeneity is one of the key simplicity requirements enabling originators and investors to properly assess the underlying risks while facilitating investors due diligence.
  • The EBA has extended the existing work on the RTS on homogeneity for both asset-backed commercial paper (ABCP) and non-ABCP securitisation in order to ensure consistency for on-balance-sheet securitisation to the overall STS framework.
  • Therefore, these draft RTS are amending the Delegated Commission Regulation (EU) 2019/1851 by extending the scope to on-balance-sheet securitisations considering the specificities of these securitisations.

Finacity, a White Oak Company, and DZ BANK Upsize Receivables Securitization for Nitron Group LLC to USD 165 Million

Retrieved on: 
Monday, November 21, 2022
Urea, Growth, CFO, DZ Bank, DZ, Phosphate, BANK, ABCP, Agent, Höchst (Frankfurt am Main), Safety, Online shopping, Bank

STAMFORD, Conn., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Finacity Corporation, a White Oak Company, (Finacity) and DZ Bank AG Deutsche Zentral-Genossenschaftsbank, Frankfurt AM Main, New York Branch (DZ BANK) announce that they have successfully upsizeda trade receivables securitization for Nitron Group LLC (Nitron), a company headquartered in Greenwich, CT.

Key Points: 
  • STAMFORD, Conn., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Finacity Corporation, a White Oak Company, (Finacity) and DZ Bank AG Deutsche Zentral-Genossenschaftsbank, Frankfurt AM Main, New York Branch (DZ BANK) announce that they have successfully upsizeda trade receivables securitization for Nitron Group LLC (Nitron), a company headquartered in Greenwich, CT.
  • The facility is collateralized by Nitrons receivables for fertilizer distribution and importation services in Latin America, North America, Europe, and Africa.
  • We remain grateful to our partners, DZ Bank and Finacity, for their continued support and confidence in Nitron.
  • DZ BANK is the second largest bank in Germany and acts as central bank for approximately 800 cooperative banks with over 8,500 branches in Germany.